Predicting chemotherapy response in non|small|cell lung cancer via ...

Predicting chemotherapy response in non-small-cell lung cancer via ...

Conclusion. Non-contrast CT radiomic features from both the peri- and intratumoral regions can predict chemotherapy response in NSCLC via ...

Predicting chemotherapy response in non-small-cell lung cancer via ...

CT radiomic features from both the peri- and intratumoral regions can predict chemotherapy response in NSCLC using machine learning models.

Predicting chemotherapy response in non-small-cell lung cancer via ...

signiﬁcant impact on the survival rate of NSCLC patients (6–10). ... response prediction at a low cost (14,15). ... operating characteristic curve ( ...

Predicting treatment response in multicenter non-small cell lung ...

Multicenter non-small cell lung cancer (NSCLC) patient data is information-rich. However, its direct integration becomes exceptionally ...

Predictors of chemotherapy efficacy in non-small-cell lung cancer

The best-validated predictive biomarkers for efficacy are currently ERCC1, RRM1, and TS for platinum agents, gemcitabine and pemetrexed, respectively.

Predicting pathological response to neoadjuvant immunotherapy ...

Predicting pathological response to neoadjuvant immunotherapy plus chemotherapy in resectable non-small cell lung cancer through liquid biopsy.

Deep multiple instance learning for predicting chemotherapy ...

The individual prognosis of chemotherapy is quite different in non-small cell lung cancer (NSCLC). There is an urgent need to precisely ...

Predictive Radiomic Models for the Chemotherapy Response in Non ...

The heterogeneity and complexity of non-small cell lung cancer (NSCLC) tumors mean that NSCLC patients at the same stage can have different chemotherapy ...

Deep learning for predicting major pathological response to ...

For early and locally advanced non-small cell lung cancer (NSCLC), a surgical resection continues to the mainstay of curative-intent therapeutic ...

Tumor Response in Patients With Advanced Non–Small Cell Lung ...

After chemoradiation therapy, findings at perfusion CT are a significant predictor of early tumor response and overall survival among patients with non–small ...

Histopathologic Response Criteria Predict Survival of Patients with ...

The percentage of residual viable tumor cells and surgical pathologic stage were associated with OS and DFS in 192 patients with NSCLC receiving neoadjuvant ...

Non-invasive multimodal CT deep learning biomarker to predict ...

Objectives Although neoadjuvant immunochemotherapy has been widely applied in non-small cell lung cancer (NSCLC), predicting treatment response remains a ...

Development of Clinical Prediction Score for Chemotherapy ... - MDPI

The outcomes of advanced non-small cell lung cancer (NSCLC) patients have been significantly improved with novel therapies, such as tyrosine ...

Predicting chemotherapy response in non-small-cell lung cancer via ...

Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined? https://doi.

Multimodal prediction of response to neoadjuvant nivolumab and ...

Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non–small cell lung cancer. Authors: Loïc ...

Early Response to Platinum-Based First-Line Chemotherapy in Non ...

Response rates in the palliative treatment of non-small cell lung cancer, with combination platinum-based chemotherapy, vary from 20% to 40%, ...

and Radiation Therapy for Non-Small Cell Lung Cancer Patients ...

Applying the model, the benefit from concurrent chemo-radiation comparing to sequential for stage III patients was predicted to be a 6.6% and ...

Pathologic Complete Response to Preoperative Chemotherapy ...

Original Article. Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two ...

Time Course of Early Response to Chemotherapy in Non–Small ...

PET and 18F-FDG have the potential to follow the early metabolic response to chemotherapy in patients with non–small cell lung cancer and to predict success ...

Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI

As a class, NSCLC is usually less sensitive to chemotherapy and radiation therapy than SCLC. Patients with resectable disease may be cured by ...